Some 47 per cent of people with heart disease will develop depressive disorders.
Sunnybrook brain scientist Dr. Krista Lanctôt and research colleagues Drs. Nathan Herrmann and Paul Oh are exploring the effects of Omega-3 fatty acids on depressed patients suffering from Coronary Artery Disease (CAD).
Omega 3 is increasingly being shown to be important for both heart and brain health. A new study is looking at supplementing Omega 3 fatty acids in people who have CAD with depressive symptoms.
This research is funded by the Ontario Mental Health Foundation and now these senior scientists are able to help a new generation of researchers receive innovative training and mentoring in the area, thanks to a six-year, $1.8 million Canadian Institutes of Health Research (CIHR) Strategic Training Initiative in Health Research in Neurodegenerative Lipidomics led by Drs. Steffany Bennett and Daniel Figeys.
